All lobbying filings

THE UNITED STATES PHARMACOPEIAL CONVENTION

Lobbying for THE UNITED STATES PHARMACOPEIAL CONVENTION

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Maryland · House · Senate · $110,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 3

S 1784
MAPS Act
HR 4191
MAPS Act
S 3788
CLEAR LABELS Act

Lobbying activity 2

Health Issues

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.

Budget/Appropriations

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027: Provisions related to Administration for Strategic Preparedness and Response (ASPR) mapping. FY 2027 Commerce, Justice, Science, and Related Agencies Appropriations: Provisions related to 3D-printing. FY 2027 State-Foreign Operations Appropriations: Provisions related to pharmaceutical supply chain resilience.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.